Patents by Inventor Amriam GOLDBLUM

Amriam GOLDBLUM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Toll-like receptor 9 antagonists
    Patent number: 11104677
    Abstract: A method of preventing or treating a disease characterized by an excessive immune response in a subject in need thereof is provided. The method includes administering to the subject a composition including an active component, wherein the active component is a first compound, a second compound, a third compound, a pharmaceutically acceptable salt thereof, a solvate thereof, or a combination thereof, wherein the first, second, and third compounds include: respectively.
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: August 31, 2021
    Assignees: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V., YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD.
    Inventors: Anke Burger-Kentischer, Angela Mattes, Maria Zatsepin, Amriam Goldblum
  • NEW TOLL-LIKE RECEPTOR 9 ANTAGONISTS
    Publication number: 20200048252
    Abstract: A method of preventing or treating a disease characterized by an excessive immune response in a subject in need thereof is provided. The method includes administering to the subject a composition including an active component, wherein the active component is a first compound, a second compound, a third compound, a pharmaceutically acceptable salt thereof, a solvate thereof, or a combination thereof, wherein the first, second, and third compounds include: respectively.
    Type: Application
    Filed: October 21, 2019
    Publication date: February 13, 2020
    Applicants: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V., YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD.
    Inventors: Anke BURGER-KENTISCHER, Angela MATTES, Maria ZATSEPIN, Amriam GOLDBLUM
  • NEW TOLL-LIKE RECEPTOR 9 ANTAGONISTS
    Publication number: 20190106418
    Abstract: The present invention relates to a compound or a pharmaceutically acceptable salt thereof or a solvate thereof or a pharmaceutical composition comprising said compound, a process for obtaining or screening for a toll-like receptor 9 (TLR9) antagonist and a toll-like receptor 9 (TLR9) antagonist or a pharmaceutically acceptable salt thereof or a solvate thereof, preferably being obtainable thereby.
    Type: Application
    Filed: March 24, 2016
    Publication date: April 11, 2019
    Applicants: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWAND TEN FORSCHUNG E.V., YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD.
    Inventors: Anke BURGER-KENTISCHER, Angela MATTES, Maria ZATSEPIN, Amriam GOLDBLUM